Brandinium

Trademark search for:

GENEREX ORAL-LYN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2006-07-07 — Application filed
  • 2006-07-12 — Application filed
  • 2006-12-06 — Assigned to examiner
  • 2006-12-08 — Final disposition recorded
  • 2006-12-11 — Final disposition recorded
  • 2007-06-11 — Paper received
  • 2007-06-22 — Amendment from applicant entered
  • 2007-06-22 — Assigned to lie
  • 2007-06-22 — Correspondence received in law office
  • 2007-06-24 — Suspension letter written
  • 2007-06-25 — Letter of suspension mailed
  • 2008-01-03 — Suspension checked - to attorney for action
  • 2008-01-22 — Suspension letter written
  • 2008-01-23 — Letter of suspension mailed
  • 2008-08-19 — Assigned to lie
  • 2008-08-20 — Suspension checked - to attorney for action
  • 2008-09-12 — Suspension inquiry written
  • 2008-09-15 — Inquiry as to suspension mailed
  • 2009-01-21 — Paper received
  • 2009-01-26 — Assigned to lie
  • 2009-01-27 — Suspension letter written
  • 2009-01-27 — Amendment from applicant entered
  • 2009-01-27 — Correspondence received in law office
  • 2009-01-28 — Letter of suspension mailed
  • 2009-07-28 — Assigned to lie
  • 2009-07-28 — Suspension checked - to attorney for action
  • 2009-08-17 — Suspension inquiry written
  • 2009-08-17 — Inquiry as to suspension mailed
  • 2010-02-12 — Use amendment filed
  • 2010-02-12 — Paper received
  • 2010-02-19 — Amendment to use processing complete
  • 2010-02-19 — Amendment from applicant entered
  • 2010-02-19 — Correspondence received in law office
  • 2010-03-10 — Approved for pub - principal register
  • 2010-03-10 — Use amendment accepted
  • 2010-03-12 — Law office publication review completed
  • 2010-03-31 — Notice of publication
  • 2010-04-20 — Published for opposition
  • 2010-07-06 — Registered-principal register
  • 2017-02-10 — Cancelled sec. 8 (6-yr)
  • 2017-02-10 — Final status recorded

Owner Information

Generex Pharmaceuticals Inc.
Toronto, Ontario CA
Generex Pharmaceuticals Inc.
Toronto, Ontario CA
Generex Pharmaceuticals Inc.
Toronto, Ontario CA

Correspondent

JOHN L DUPRÉ HAMILTON, BROOK, SMITH & REYNOLDS PC
PO BOX 9133
CONCORD, MA 01742-9133
UNITED STATES

Filing Details

Filing Date:
2006-07-07
Status Date:
2017-02-10
Category:
Pharmaceuticals
Filing Year:
2006

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.